Science reporter magazine
science reporter magazine Tipper
TCV is the world's first typhoid vaccine clinically proven to be given to
children from 6 months age to adults and ensures long term protection against
Typhoid fever. Human Challenges Studies at Oxford University has evaluated it.
TCV is an innovative product possessing long-term lasting effect as compared to
the older vaccine and requires fewer doses. They could be given to a young
child through routine childhood immunization programmed. TCV has been
recommended by the World Health Organization (WHO) Strategic Advisory Group of
Experts on Immunization (WHO-SAGE) science reporter subscribe this magazine.
Science reporter magazine WHO
Okays Indian Typhoid Vaccine for Global Use World Health Organization (WHO) has
given its prequalification to Tipper Typhoid Conjugate Vaccine (TCV) which has
been developed by Bharat Biotech of Hyderabad, India.
No comments:
Post a Comment